Oncolytics Biotech Inc (NAS:ONCY)
$ 1.11 0.04 (3.7%) Market Cap: 85.56 Mil Enterprise Value: 65.27 Mil PE Ratio: 0 PB Ratio: 6.59 GF Score: 37/100

Q3 2019 Oncolytics Biotech Inc Earnings Call Transcript

Nov 12, 2019 / 10:00PM GMT
Release Date Price: $1.02 (+0.99%)
Operator

Good day, ladies and gentlemen. My name is Kat, and I'll be your conference operator today. At this time, I would like to welcome everyone to Analytics (sic) [Oncolytics] Biotech Third Quarter 2019 Results Conference Call. (Operator Instructions) I will now turn the call over to your host, Michael Moore, Vice President, Investor Relations and Corporate Communications. Sir, the floor is yours.

Michael Moore
Oncolytics Biotech Inc. - VP of IR & Corporate Communications

Thanks, Kat. Good afternoon, ladies and gentlemen, and thank you for joining us on our call today to discuss our third quarter and corporate update, including our updated catalyst milestones. With me on the call this afternoon from Oncolytics are Dr. Matt Coffey, President and Chief Executive Officer; Kirk Look, Chief Financial Officer; and Andrew de Guttadauro, Global Head of Business Development.

On today's call, Dr. Coffey will review our clinical and operational progress, including a recap of catalyst milestones. Andrew will touch on our business development progress and our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot